Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

212,551-212,580 of 319,975

filter-aware
21
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
22
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
23
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
24
The slide features the Renovaro Biosciences logo and a stylized botanical/cellular graphic background.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
25
The slide uses a process flow diagram to explain the therapeutic intervention.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
26
The slide uses a chevron-style process flow to represent chronological progress.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
27
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
28
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
29
The chart shows a significant drop in viral load starting around day 14, stabilizing at a low level from day 145 onwards.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
30
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
31
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
32
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
33
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
34
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
35
The slide uses a comparative diagram to illustrate the selective mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
36
The slide uses a ribbon-style process diagram to represent sequential or cumulative progress.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
37
The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
38
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
39
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
40
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
41
The slide uses a horizontal arrow-based timeline structure to map specific drug candidates to their upcoming regulatory and clinical milestones.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
42
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
43
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
01
Slide 1
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
02
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a background image of an Eos energy storage container.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
04
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a three-pillar structure to explain the transition from Gen 2.3 to Z3.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a three-column layout to categorize manufacturing progress into production status, system assembly, and future design.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide uses a dual-axis-like conceptual chart to show price vs cost convergence, with a callout for IRA impact.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit